World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02484183
Date of registration: 23/06/2015
Prospective Registration: Yes
Primary sponsor: Johns Hopkins University
Public title: CPAP Improving Mortality for Pneumonia in African Children Trial IMPACT
Scientific title: Effectiveness of Bubble Continuous Positive Airway Pressure (CPAP) in Reducing Childhood Pneumonia Mortality in Malawi
Date of first enrolment: June 23, 2015
Target sample size: 646
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT02484183
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Malawi
Contacts
Name:     Eric D McCollum, MD
Address: 
Telephone:
Email:
Affiliation:  Johns Hopkins School of Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- Meets World Health Organization (WHO) severe pneumonia criteria and is either Human
Immunodeficiency Virus (HIV)-infected, HIV-exposed, severely malnourished, or has
severe hypoxemia without HIV-infection, HIV-exposure, or severe malnutrition.

Exclusion Criteria:

- Any psychosocial condition or circumstance that, in the opinion of the investigators,
would interfere with the conduct of the study. Prior participation in the study during
a previous pneumonia diagnosis.



Age minimum: 1 Month
Age maximum: 59 Months
Gender: All
Health Condition(s) or Problem(s) studied
Human Immunodeficiency Virus (HIV)
Pneumonia
Hypoxemia
Malnutrition
Intervention(s)
Device: bubble continuous positive airway pressure (CPAP)
Primary Outcome(s)
Pneumonia mortality [Time Frame: Participants followed for duration of hospital stay, an expected average of 7 days]
Secondary Outcome(s)
Treatment failure [Time Frame: 14 days]
Post-discharge mortality [Time Frame: 30 days after hospital discharge.]
Relapse [Time Frame: 30 days]
Secondary ID(s)
IRB00055734
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of North Carolina, Chapel Hill
Ministry of Health and Population, Malawi
University of Utah
Children's Hospital Medical Center, Cincinnati
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history